CIK 0001651308
- Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981209416
- Phone
- +41 616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- 4 Open-market sale Director sold 8,000 shares at an average $189.86 ($1,518,845)
- 4 Open-market sale Director sold 2,000 shares at an average $180.00 ($360,000)
- 4 Open-market sale President & GM China sold 1,000 shares at $180.00 ($180,000)
- 4 Open-market sale CMO, Hematology sold 2,944 shares at an average $144.03 ($424,030)
- 4 Open-market sale Director sold 8,614 shares at an average $144.96 ($1,248,680)
- 4 Other disposition Director disposed of 39,484 shares (other)
- 4 Open-market sale CMO, Hematology sold 2,500 shares at an average $134.74 ($336,855)
- 4 Open-market sale CMO, Hematology sold 10,130 shares at an average $134.54 ($1,362,896)
- 4 Open-market sale Chief Executive Officer sold 3,106 shares at an average $126.87 ($394,055)
- 4 Open-market sale CMO, Hematology sold 430 shares at an average $124.52 ($53,542)
- 4 Open-market sale CFO & Chief Strategy Officer sold 5,876 shares at $9.47 ($55,653)
- 4 Open-market sale Director sold 4,847 shares at an average $126.46 ($612,937)
- 4 Other disposition Director disposed of 9,282 shares (other)
- 4 Derivatives Options or other derivatives
- 4 Other disposition Director disposed of 764,739 shares (other)
- 4 Grant or award CMO, Hematology acquired 62,842 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award CFO & Chief Strategy Officer acquired 75,855 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award President & GM China acquired 433,472 shares (grant or award)
Page 22 of 29 · 580 filings